The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2021 | Challenges in grade 3B follicular lymphoma management
Eliza A. Hawkes, MBBS Hons, FRACP, DMedSc, Olivia Newton-John Cancer Centre, Melbourne, Australia, describes the diagnostic and therapeutic challenges of grade 3B follicular lymphoma (FL), a rare form of FL. Grade 3B FL is hard to accurately diagnose due to inconsistent results from immunohistochemical staining techniques. The heterogenous nature of FL can also make forming consistent treatment strategies difficult, where patients with grade 3B FL can simultaneously have lower grade FL or diffuse large B-cell lymphoma (DLBCL). Improving patient outcomes will require optimizing diagnostics and treatment of grade 3B FL. This interview took place during the 2021 International Conference on Malignant Lymphoma (16-ICML).
